HEADER TRANSFERASE 25-JAN-25 7I01 TITLE PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF ENTEROCOCCUS TITLE 2 FAECIUM VATD IN COMPLEX WITH ZINC000000388593 COMPND MOL_ID: 1; COMPND 2 MOLECULE: STREPTOGRAMIN A ACETYLTRANSFERASE; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: VIRGINIAMYCIN ACETYLTRANSFERASE D,VAT(D); COMPND 5 EC: 2.3.1.-; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: HIS6 PURIFICATION TAG (MGSSHHHHHHENLYFQ) CLEAVED WITH COMPND 8 TEV PROTEASE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ENTEROCOCCUS FAECIUM; SOURCE 3 ORGANISM_TAXID: 1352; SOURCE 4 GENE: VATD, SATA; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS VATD, ANTIBIOTIC RESISTANCE, STREPTOGRAMIN, FRAGMENT-BASED DRUG KEYWDS 2 DISCOVERY, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR P.ASTHANA,J.S.FRASER REVDAT 1 28-JAN-26 7I01 0 JRNL AUTH P.ASTHANA,J.S.FRASER JRNL TITL LIGAND SCREEN AGAINST ENTEROCOCCUS FAECIUM VATD JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.16 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.16 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.25 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 36312 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.221 REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.275 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 1843 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.2500 - 5.0900 1.00 2843 161 0.1796 0.2153 REMARK 3 2 5.0900 - 4.0400 1.00 2712 143 0.1551 0.2265 REMARK 3 3 4.0400 - 3.5300 1.00 2693 149 0.1982 0.2602 REMARK 3 4 3.5300 - 3.2100 1.00 2648 144 0.2347 0.2753 REMARK 3 5 3.2100 - 2.9800 1.00 2641 146 0.2809 0.3291 REMARK 3 6 2.9800 - 2.8000 1.00 2640 145 0.2580 0.3378 REMARK 3 7 2.8000 - 2.6600 1.00 2651 119 0.2846 0.3776 REMARK 3 8 2.6600 - 2.5500 1.00 2656 127 0.3088 0.4140 REMARK 3 9 2.5400 - 2.4500 0.99 2563 144 0.3230 0.3842 REMARK 3 10 2.4500 - 2.3600 1.00 2624 144 0.2971 0.3178 REMARK 3 11 2.3600 - 2.2900 1.00 2627 145 0.2874 0.3543 REMARK 3 12 2.2900 - 2.2200 1.00 2577 131 0.2942 0.3360 REMARK 3 13 2.2200 - 2.1600 0.98 2594 145 0.3410 0.3795 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.390 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.430 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 53.54 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 69.17 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7I01 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-JAN-25. REMARK 100 THE DEPOSITION ID IS D_1001408145. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-SEP-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.11583 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS JUN 30, 2023 REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.9 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36401 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.160 REMARK 200 RESOLUTION RANGE LOW (A) : 49.010 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.08600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.16 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 6.50 REMARK 200 R MERGE FOR SHELL (I) : 1.91800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.3 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS, 25% PEG 1000, PH 8.0, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.10200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 73.51250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 51.07650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 73.51250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.10200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 51.07650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8180 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26420 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -40.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 VAL A 205 REMARK 465 ILE A 206 REMARK 465 TRP A 207 REMARK 465 LYS A 208 REMARK 465 LYS A 209 REMARK 465 GLY B 1 REMARK 465 VAL B 205 REMARK 465 ILE B 206 REMARK 465 TRP B 207 REMARK 465 LYS B 208 REMARK 465 LYS B 209 REMARK 465 GLY C 1 REMARK 465 GLU C 204 REMARK 465 VAL C 205 REMARK 465 ILE C 206 REMARK 465 TRP C 207 REMARK 465 LYS C 208 REMARK 465 LYS C 209 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 H LYS A 104 OE1 GLN A 107 1.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET C 77 CG - SD - CE ANGL. DEV. = 10.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 35 -20.15 77.40 REMARK 500 ILE A 110 122.86 -37.72 REMARK 500 ASN A 199 2.71 80.11 REMARK 500 TYR B 9 76.88 -118.92 REMARK 500 ASN B 14 74.29 -154.21 REMARK 500 LYS B 26 -5.64 79.36 REMARK 500 TYR B 35 -14.63 73.05 REMARK 500 ASN B 42 25.51 -141.36 REMARK 500 MET B 84 -0.63 -144.43 REMARK 500 HIS B 101 32.21 -90.04 REMARK 500 ASN B 199 -0.90 71.83 REMARK 500 TYR C 35 -17.28 72.27 REMARK 500 HIS C 101 46.92 -97.72 REMARK 500 PRO C 109 140.37 -33.69 REMARK 500 REMARK 500 REMARK: NULL DBREF 7I01 A 2 209 UNP P50870 VATD_ENTFC 2 209 DBREF 7I01 B 2 209 UNP P50870 VATD_ENTFC 2 209 DBREF 7I01 C 2 209 UNP P50870 VATD_ENTFC 2 209 SEQADV 7I01 GLY A 1 UNP P50870 EXPRESSION TAG SEQADV 7I01 GLY B 1 UNP P50870 EXPRESSION TAG SEQADV 7I01 GLY C 1 UNP P50870 EXPRESSION TAG SEQRES 1 A 209 GLY GLY PRO ASN PRO MET LYS MET TYR PRO ILE GLU GLY SEQRES 2 A 209 ASN LYS SER VAL GLN PHE ILE LYS PRO ILE LEU GLU LYS SEQRES 3 A 209 LEU GLU ASN VAL GLU VAL GLY GLU TYR SER TYR TYR ASP SEQRES 4 A 209 SER LYS ASN GLY GLU THR PHE ASP LYS GLN ILE LEU TYR SEQRES 5 A 209 HIS TYR PRO ILE LEU ASN ASP LYS LEU LYS ILE GLY LYS SEQRES 6 A 209 PHE CYS SER ILE GLY PRO GLY VAL THR ILE ILE MET ASN SEQRES 7 A 209 GLY ALA ASN HIS ARG MET ASP GLY SER THR TYR PRO PHE SEQRES 8 A 209 ASN LEU PHE GLY ASN GLY TRP GLU LYS HIS MET PRO LYS SEQRES 9 A 209 LEU ASP GLN LEU PRO ILE LYS GLY ASP THR ILE ILE GLY SEQRES 10 A 209 ASN ASP VAL TRP ILE GLY LYS ASP VAL VAL ILE MET PRO SEQRES 11 A 209 GLY VAL LYS ILE GLY ASP GLY ALA ILE VAL ALA ALA ASN SEQRES 12 A 209 SER VAL VAL VAL LYS ASP ILE ALA PRO TYR MET LEU ALA SEQRES 13 A 209 GLY GLY ASN PRO ALA ASN GLU ILE LYS GLN ARG PHE ASP SEQRES 14 A 209 GLN ASP THR ILE ASN GLN LEU LEU ASP ILE LYS TRP TRP SEQRES 15 A 209 ASN TRP PRO ILE ASP ILE ILE ASN GLU ASN ILE ASP LYS SEQRES 16 A 209 ILE LEU ASP ASN SER ILE ILE ARG GLU VAL ILE TRP LYS SEQRES 17 A 209 LYS SEQRES 1 B 209 GLY GLY PRO ASN PRO MET LYS MET TYR PRO ILE GLU GLY SEQRES 2 B 209 ASN LYS SER VAL GLN PHE ILE LYS PRO ILE LEU GLU LYS SEQRES 3 B 209 LEU GLU ASN VAL GLU VAL GLY GLU TYR SER TYR TYR ASP SEQRES 4 B 209 SER LYS ASN GLY GLU THR PHE ASP LYS GLN ILE LEU TYR SEQRES 5 B 209 HIS TYR PRO ILE LEU ASN ASP LYS LEU LYS ILE GLY LYS SEQRES 6 B 209 PHE CYS SER ILE GLY PRO GLY VAL THR ILE ILE MET ASN SEQRES 7 B 209 GLY ALA ASN HIS ARG MET ASP GLY SER THR TYR PRO PHE SEQRES 8 B 209 ASN LEU PHE GLY ASN GLY TRP GLU LYS HIS MET PRO LYS SEQRES 9 B 209 LEU ASP GLN LEU PRO ILE LYS GLY ASP THR ILE ILE GLY SEQRES 10 B 209 ASN ASP VAL TRP ILE GLY LYS ASP VAL VAL ILE MET PRO SEQRES 11 B 209 GLY VAL LYS ILE GLY ASP GLY ALA ILE VAL ALA ALA ASN SEQRES 12 B 209 SER VAL VAL VAL LYS ASP ILE ALA PRO TYR MET LEU ALA SEQRES 13 B 209 GLY GLY ASN PRO ALA ASN GLU ILE LYS GLN ARG PHE ASP SEQRES 14 B 209 GLN ASP THR ILE ASN GLN LEU LEU ASP ILE LYS TRP TRP SEQRES 15 B 209 ASN TRP PRO ILE ASP ILE ILE ASN GLU ASN ILE ASP LYS SEQRES 16 B 209 ILE LEU ASP ASN SER ILE ILE ARG GLU VAL ILE TRP LYS SEQRES 17 B 209 LYS SEQRES 1 C 209 GLY GLY PRO ASN PRO MET LYS MET TYR PRO ILE GLU GLY SEQRES 2 C 209 ASN LYS SER VAL GLN PHE ILE LYS PRO ILE LEU GLU LYS SEQRES 3 C 209 LEU GLU ASN VAL GLU VAL GLY GLU TYR SER TYR TYR ASP SEQRES 4 C 209 SER LYS ASN GLY GLU THR PHE ASP LYS GLN ILE LEU TYR SEQRES 5 C 209 HIS TYR PRO ILE LEU ASN ASP LYS LEU LYS ILE GLY LYS SEQRES 6 C 209 PHE CYS SER ILE GLY PRO GLY VAL THR ILE ILE MET ASN SEQRES 7 C 209 GLY ALA ASN HIS ARG MET ASP GLY SER THR TYR PRO PHE SEQRES 8 C 209 ASN LEU PHE GLY ASN GLY TRP GLU LYS HIS MET PRO LYS SEQRES 9 C 209 LEU ASP GLN LEU PRO ILE LYS GLY ASP THR ILE ILE GLY SEQRES 10 C 209 ASN ASP VAL TRP ILE GLY LYS ASP VAL VAL ILE MET PRO SEQRES 11 C 209 GLY VAL LYS ILE GLY ASP GLY ALA ILE VAL ALA ALA ASN SEQRES 12 C 209 SER VAL VAL VAL LYS ASP ILE ALA PRO TYR MET LEU ALA SEQRES 13 C 209 GLY GLY ASN PRO ALA ASN GLU ILE LYS GLN ARG PHE ASP SEQRES 14 C 209 GLN ASP THR ILE ASN GLN LEU LEU ASP ILE LYS TRP TRP SEQRES 15 C 209 ASN TRP PRO ILE ASP ILE ILE ASN GLU ASN ILE ASP LYS SEQRES 16 C 209 ILE LEU ASP ASN SER ILE ILE ARG GLU VAL ILE TRP LYS SEQRES 17 C 209 LYS HET DMD B 301 21 HETNAM DMD 5,6-DIMETHYLBENZIMIDAZOLE FORMUL 4 DMD C9 H10 N2 FORMUL 5 HOH *39(H2 O) HELIX 1 AA1 ILE A 20 LEU A 24 1 5 HELIX 2 AA2 THR A 45 LYS A 48 5 4 HELIX 3 AA3 TYR A 54 ASN A 58 5 5 HELIX 4 AA4 ASN A 78 ASN A 81 5 4 HELIX 5 AA5 PRO A 90 GLY A 95 5 6 HELIX 6 AA6 GLY A 97 MET A 102 5 6 HELIX 7 AA7 LYS A 104 LEU A 108 5 5 HELIX 8 AA8 ASP A 169 LYS A 180 1 12 HELIX 9 AA9 TRP A 181 TRP A 184 5 4 HELIX 10 AB1 PRO A 185 GLU A 191 1 7 HELIX 11 AB2 ASN A 192 ASN A 199 1 8 HELIX 12 AB3 SER A 200 GLU A 204 5 5 HELIX 13 AB4 THR B 45 LYS B 48 5 4 HELIX 14 AB5 TYR B 54 ASN B 58 5 5 HELIX 15 AB6 ASN B 78 ASN B 81 5 4 HELIX 16 AB7 PRO B 90 GLY B 95 5 6 HELIX 17 AB8 GLY B 97 MET B 102 5 6 HELIX 18 AB9 LYS B 104 LEU B 108 5 5 HELIX 19 AC1 ASP B 169 LYS B 180 1 12 HELIX 20 AC2 TRP B 181 TRP B 184 5 4 HELIX 21 AC3 PRO B 185 GLU B 191 1 7 HELIX 22 AC4 ASN B 192 ASP B 198 1 7 HELIX 23 AC5 ASN B 199 ARG B 203 5 5 HELIX 24 AC6 ILE C 20 LEU C 24 1 5 HELIX 25 AC7 THR C 45 LYS C 48 5 4 HELIX 26 AC8 TYR C 54 ASN C 58 5 5 HELIX 27 AC9 ASN C 78 ASN C 81 5 4 HELIX 28 AD1 PRO C 90 PHE C 94 5 5 HELIX 29 AD2 LYS C 104 LEU C 108 5 5 HELIX 30 AD3 ASP C 169 LYS C 180 1 12 HELIX 31 AD4 TRP C 181 TRP C 184 5 4 HELIX 32 AD5 PRO C 185 GLU C 191 1 7 HELIX 33 AD6 ASN C 192 ASP C 198 1 7 HELIX 34 AD7 ASN C 199 ARG C 203 5 5 SHEET 1 AA1 7 VAL A 17 PHE A 19 0 SHEET 2 AA1 7 TYR A 37 ASP A 39 -1 O TYR A 38 N GLN A 18 SHEET 3 AA1 7 SER A 68 ILE A 69 1 O ILE A 69 N TYR A 37 SHEET 4 AA1 7 TRP A 121 ILE A 122 1 O ILE A 122 N SER A 68 SHEET 5 AA1 7 ILE A 139 VAL A 140 1 O VAL A 140 N TRP A 121 SHEET 6 AA1 7 MET A 154 GLY A 157 1 O MET A 154 N ILE A 139 SHEET 7 AA1 7 ASN A 162 GLN A 166 -1 O LYS A 165 N LEU A 155 SHEET 1 AA2 4 VAL A 30 VAL A 32 0 SHEET 2 AA2 4 LEU A 61 ILE A 63 1 O ILE A 63 N GLU A 31 SHEET 3 AA2 4 THR A 114 ILE A 116 1 O ILE A 116 N LYS A 62 SHEET 4 AA2 4 LYS A 133 ILE A 134 1 O ILE A 134 N ILE A 115 SHEET 1 AA3 4 ILE A 50 LEU A 51 0 SHEET 2 AA3 4 THR A 74 ILE A 76 1 O ILE A 75 N LEU A 51 SHEET 3 AA3 4 VAL A 127 ILE A 128 1 O ILE A 128 N ILE A 76 SHEET 4 AA3 4 VAL A 145 VAL A 146 1 O VAL A 146 N VAL A 127 SHEET 1 AA4 7 VAL B 17 PHE B 19 0 SHEET 2 AA4 7 TYR B 37 ASP B 39 -1 O TYR B 38 N GLN B 18 SHEET 3 AA4 7 SER B 68 ILE B 69 1 O ILE B 69 N TYR B 37 SHEET 4 AA4 7 TRP B 121 ILE B 122 1 O ILE B 122 N SER B 68 SHEET 5 AA4 7 ILE B 139 VAL B 140 1 O VAL B 140 N TRP B 121 SHEET 6 AA4 7 MET B 154 GLY B 157 1 O ALA B 156 N ILE B 139 SHEET 7 AA4 7 ASN B 162 GLN B 166 -1 O ILE B 164 N LEU B 155 SHEET 1 AA5 4 VAL B 30 VAL B 32 0 SHEET 2 AA5 4 LEU B 61 ILE B 63 1 O ILE B 63 N GLU B 31 SHEET 3 AA5 4 THR B 114 ILE B 116 1 O ILE B 116 N LYS B 62 SHEET 4 AA5 4 LYS B 133 ILE B 134 1 O ILE B 134 N ILE B 115 SHEET 1 AA6 4 ILE B 50 LEU B 51 0 SHEET 2 AA6 4 THR B 74 ILE B 76 1 O ILE B 75 N LEU B 51 SHEET 3 AA6 4 VAL B 127 ILE B 128 1 O ILE B 128 N ILE B 76 SHEET 4 AA6 4 VAL B 145 VAL B 146 1 O VAL B 146 N VAL B 127 SHEET 1 AA7 7 VAL C 17 PHE C 19 0 SHEET 2 AA7 7 TYR C 37 ASP C 39 -1 O TYR C 38 N GLN C 18 SHEET 3 AA7 7 SER C 68 ILE C 69 1 O ILE C 69 N ASP C 39 SHEET 4 AA7 7 TRP C 121 ILE C 122 1 O ILE C 122 N SER C 68 SHEET 5 AA7 7 ILE C 139 VAL C 140 1 O VAL C 140 N TRP C 121 SHEET 6 AA7 7 MET C 154 GLY C 157 1 O ALA C 156 N ILE C 139 SHEET 7 AA7 7 ASN C 162 GLN C 166 -1 O ILE C 164 N LEU C 155 SHEET 1 AA8 4 VAL C 30 VAL C 32 0 SHEET 2 AA8 4 LEU C 61 ILE C 63 1 O ILE C 63 N GLU C 31 SHEET 3 AA8 4 THR C 114 ILE C 116 1 O ILE C 116 N LYS C 62 SHEET 4 AA8 4 LYS C 133 ILE C 134 1 O ILE C 134 N ILE C 115 SHEET 1 AA9 4 ILE C 50 LEU C 51 0 SHEET 2 AA9 4 THR C 74 ILE C 76 1 O ILE C 75 N LEU C 51 SHEET 3 AA9 4 VAL C 127 ILE C 128 1 O ILE C 128 N ILE C 76 SHEET 4 AA9 4 VAL C 145 VAL C 146 1 O VAL C 146 N VAL C 127 CISPEP 1 ASN A 159 PRO A 160 0 -1.97 CISPEP 2 ASN B 159 PRO B 160 0 -0.55 CISPEP 3 ASN C 159 PRO C 160 0 4.50 CRYST1 44.204 102.153 147.025 90.00 90.00 90.00 P 21 21 21 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022622 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009789 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006802 0.00000 CONECT 9827 9829 9831 9838 CONECT 9828 9829 9830 CONECT 9829 9827 9828 9839 CONECT 9830 9828 9831 9835 CONECT 9831 9827 9830 9832 CONECT 9832 9831 9833 9840 CONECT 9833 9832 9834 9836 CONECT 9834 9833 9835 9837 CONECT 9835 9830 9834 9841 CONECT 9836 9833 9842 9843 9844 CONECT 9837 9834 9845 9846 9847 CONECT 9838 9827 CONECT 9839 9829 CONECT 9840 9832 CONECT 9841 9835 CONECT 9842 9836 CONECT 9843 9836 CONECT 9844 9836 CONECT 9845 9837 CONECT 9846 9837 CONECT 9847 9837 MASTER 290 0 1 34 45 0 0 6 4871 3 21 51 END